- Home
- KROS vs DXYZ Comparison
KROS vs DXYZ Comparison
Compare KROS & DXYZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- DXYZ
- Stock Information
- Founded
- KROS 2015
- DXYZ N/A
- Country
- KROS United States
- DXYZ
- Employees
- KROS N/A
- DXYZ N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- DXYZ
- Sector
- KROS Health Care
- DXYZ
- Exchange
- KROS Nasdaq
- DXYZ Nasdaq
- Market Cap
- KROS 565.0M
- DXYZ 313.1M
- IPO Year
- KROS 2020
- DXYZ 2024
- Fundamental
- Price
- KROS $15.62
- DXYZ $25.83
- Analyst Decision
- KROS Buy
- DXYZ
- Analyst Count
- KROS 14
- DXYZ 0
- Target Price
- KROS $20.56
- DXYZ N/A
- AVG Volume (30 Days)
- KROS 412.4K
- DXYZ N/A
- Earning Date
- KROS 11-05-2025
- DXYZ N/A
- Dividend Yield
- KROS N/A
- DXYZ N/A
- EPS Growth
- KROS N/A
- DXYZ N/A
- EPS
- KROS 0.47
- DXYZ N/A
- Revenue
- KROS $232,844,000.00
- DXYZ N/A
- Revenue This Year
- KROS $5,998.31
- DXYZ N/A
- Revenue Next Year
- KROS N/A
- DXYZ N/A
- P/E Ratio
- KROS $33.74
- DXYZ N/A
- Revenue Growth
- KROS 85820.30
- DXYZ N/A
- 52 Week Low
- KROS $9.12
- DXYZ N/A
- 52 Week High
- KROS $72.37
- DXYZ N/A
- Technical
- Relative Strength Index (RSI)
- KROS 57.13
- DXYZ 36.40
- Support Level
- KROS $15.34
- DXYZ $26.00
- Resistance Level
- KROS $15.85
- DXYZ $27.95
- Average True Range (ATR)
- KROS 0.45
- DXYZ 0.92
- MACD
- KROS -0.02
- DXYZ 0.16
- Stochastic Oscillator
- KROS 57.08
- DXYZ 8.75
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About DXYZ Destiny Tech100 Inc. Common Stock
Destiny Tech100 Inc is a non-diversified, closed-end management investment company. It invests in a portfolio of what is believed to be 100 of the top venture-backed private technology companies.